Introduction
Dragon Pharma Superdrol 10 is presented in a 100-tablet pouch. Each tablet is labeled to contain 10 milligrams of methyldrostanolone, although the active ingredient is misspelled on the pouch label as methylclrostanolone. This discrepancy highlights the importance of independent verification of product labeling and content. To ensure transparency and product accuracy, AnabolicLab procured samples of this product from a European-based internet source. These samples were purchased between May 15, 2018, and June 21, 2018, and submitted to SIMEC AG, an internationally accredited analytical laboratory, for testing.
AnabolicLab funded the analysis in full, which included HPLC-UV quantitative dosage testing. The findings confirmed that the product met its label claim within an acceptable variance. This independent analysis is published as part of AnabolicLab’s commitment to harm reduction, providing consumers with accurate and unbiased information about the products they may encounter.
Testing Results and Authentication
The samples were received by SIMEC AG on June 21, 2018, and the report was finalized on October 26, 2018.
The product was identified with:
- Batch Number: DPSP-01
- Expiration Date: October 2019
Product Overview
- Manufacturer: Dragon Pharma
- Product Name: Superdrol 10
- Active Ingredient: Methyldrostanolone
- Batch Number: DPSP-01
- Expiration Date: October 2019
- Delivery Method: Oral (tablet form)
- Specification: 10 mg/tablet methyldrostanolone
Sample Acquisition and Testing
- Date Purchased: Between May 15, 2018, and June 21, 2018
- Source: European-based internet supplier
- Product Submitted By: AnabolicLab
- Analysis Paid For By: AnabolicLab
- Analysis Performed By: SIMEC AG
- Date Received by Lab: June 21, 2018
- Date Report Completed: October 26, 2018
Testing Results
Quantitative Dosage Testing (HPLC-UV):
- Claimed Dosage: 10 mg/tablet methyldrostanolone
- Measured Dosage: 9.72 mg/tablet methyldrostanolone
- Accuracy: 97.2% (slightly below label claim)
- Variance: -2.8% (measured dosage fell short of label claim by 2.8%)
Summary
The analysis of Dragon Pharma Superdrol 10 revealed a measured concentration of 9.72 mg/tablet methyldrostanolone, which represents a 2.8% variance below the label claim. While this minor discrepancy falls within acceptable limits, the misspelling of the active ingredient on the label (methylclrostanolone) highlights potential labeling inconsistencies. This analysis underscores the importance of independent testing in verifying product content and labeling accuracy. By publishing these findings, AnabolicLab continues to prioritize transparency and accountability in the anabolic steroid market.
Commitment to Harm Reduction
AnabolicLab is dedicated to reducing harm by conducting independent analyses and publishing accurate results. This approach helps consumers verify product quality, promotes accountability among manufacturers, and mitigates risks in the anabolic steroid market.
Disclaimer
The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.
Discuss the Dragon Pharma Superdrol 10 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
